| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | March, 2023  Vol. 41  No.1 Previous Issue | Next Issue | Archive
In this issue:



Editorial
Less is more: level IB-sparing radiation therapy in nasopharyngeal cancer
Dongryul Oh
Radiat Oncol J. 2023;41(1):1-3.   Published online March 28, 2023
Review Article
A practical review of watch-and-wait approach in rectal cancer
Hwa Kyung Byun, Woong Sub Koom
Radiat Oncol J. 2023;41(1):4-11.   Published online March 28, 2023
Rectal resection surgery after neoadjuvant treatment has been the mainstay treatment of locally advanced rectal cancer. However, functional outcomes and quality of life after radical resection of the rectum remain suboptimal. The excellent oncologic outcomes in patients who achieved pathologic complete response after neoadjuvant treatment questioned the need for radical surgery. The watch-and-wait approach is a noninvasive therapeutic alternative for...
Original Articles
Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases
Marcus A. Florez, Brian De, Bhavana V. Chapman, Anussara Prayongrat, Jonathan G. Thomas, Thomas H. Beckham, Chenyang Wang, Debra N. Yeboa, Andrew J. Bishop, Tina Briere, Behrang Amini, Jing Li, Claudio E. Tatsui, Laurence D. Rhines, Amol J. Ghia
Radiat Oncol J. 2023;41(1):12-22.   Published online March 14, 2023

Purpose: There has been limited work assessing the use of re-irradiation (re-RT) for local failure following stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conventionally-fractionated external beam radiation (cEBRT) for salvage therapy following SSRS local failure. Materials and Methods: We performed a retrospective review of 54 patients that underwent salvage conventional re-RT at previously SSRS-treated sites. Local control...
Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
Sergey Nikolaevich Novikov, Irina Aleksandrovna Baldueva, Anton Yurievich Zozulya, Natalya Viktorovna Emelyanova, Dmitriy Viktorovich Girdyuk, Andrey Ivanovich Arsenyev, Elena Alexandrovna, Elena Ivanovna Tyuryaeva, E. I. Filip Evgenevich Antipov, Mikhail Markovich Girshovich, Sergey Vasilevich Kanayev
Radiat Oncol J. 2023;41(1):23-31.   Published online February 27, 2023

Purpose: To perform the analysis of the peripheral blood lymphocyte changes after stereotactic ablative radiotherapy (SABR) in patients with oligometastatic cancers. Materials and Methods: The dynamics of the immune status in peripheral blood was prospectively evaluated in 46 patients with lung (17 cases) or liver (29 cases) metastases treated by SABR. Flow cytometry of peripheral blood lymphocyte subpopulations was performed before...
Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors
Won Kyung Cho, Junnam Lee, Sung-Min Youn, Dongryul Oh, Do Hoon Lim, Han Gyul Yoon, Eun-Hae Cho, Jae Myoung Noh
Radiat Oncol J. 2023;41(1):32-39.   Published online March 28, 2023

Purpose: This study explored the potential feasibility of cell-free DNA (cfDNA) in monitoring treatment response through the measurement of chromosomal instabilities using I-scores in the context of radiation therapy (RT) for other solid tumors. Materials and Methods: This study enrolled 23 patients treated with RT for lung, esophageal, and head and neck cancer. Serial cfDNA monitoring was performed before RT, 1...
Low body mass index is associated with poor treatment outcome following radiotherapy in esophageal squamous cell carcinoma
Ji-young Lee, Yunseon Choi
Radiat Oncol J. 2023;41(1):40-47.   Published online March 22, 2023

Purpose: We aimed to determine whether patients with esophageal cancer with a low baseline body mass index (BMI) have a poor prognosis following radiotherapy (RT). Materials and Methods: We retrospectively analyzed data from 50 patients with esophageal cancer to determine whether a low starting BMI (before RT) was associated with a poor outcome. All study participants were diagnosed with non-metastatic esophageal...
Excluding prepontine cistern from whole ventricle radiotherapy target volume in localized germinoma
Hyejo Ryu, Joo Ho Lee
Radiat Oncol J. 2023;41(1):48-57.   Published online March 28, 2023

Purpose: The target delineation of whole ventricle radiotherapy (WVRT) in germinoma varies among radiation oncologists, especially regarding the inclusion of the prepontine cistern (PC). We evaluated the outcome of PC-sparing WVRT in localized germinoma. Materials and Methods: We identified 87 localized intracranial germinoma patients who received radiotherapy (RT) following chemotherapy between 1999 and 2020. By institutional policy, RT for...
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next